These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
Ontario, Canada
|
|
98-1220792
|
|
(State or other jurisdiction of incorporation or organization)
|
|
(IRS Employer Identification No.)
|
|
|
|
|
|
895 Don Mills Road, Bldg. 2, Suite 900
|
|
|
|
Toronto, Ontario, Canada, M3C 1W3
|
|
|
|
(Address of principal executive offices)
|
|
|
|
Title of Each Class
|
|
Name of Each Exchange on Which Registered
|
|
Common Shares
|
|
NASDAQ Capital Market
|
|
|
|
|
|
Page
|
|
Item 1.
|
Business
|
|
|
Item 1A.
|
Risk Factors
|
|
|
Item 1B.
|
Unresolved Staff Comments
|
|
|
Item 2.
|
Properties
|
|
|
Item 3.
|
Legal Proceedings
|
|
|
Item 4.
|
Mine Safety Disclosures
|
|
|
Item 5.
|
Market For Registrant’s Common Equity, Related Stockholder Matters and Issuer
Purchases of Equity Securities
|
|
|
Item 6.
|
Selected Financial Data
|
|
|
Item 7.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
|
|
Item 7A.
|
Quantitative and Qualitative Disclosures About Market Risk
|
|
|
Item 8.
|
Financial Statements and Supplementary Data
|
|
|
Item 9.
|
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
|
|
|
Item 9A.
|
Controls and Procedures
|
|
|
Item 9B.
|
Other Information
|
|
|
Item 10.
|
Directors, Executive Officers and Corporate Governance
|
|
|
Item 11.
|
Executive Compensation
|
|
|
Item 12.
|
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
|
|
|
Item 13.
|
Certain Relationship and Related Transactions, and Director Independence
|
|
|
Item 14.
|
Principal Accounting Fees and Services
|
|
|
Item 15.
|
Exhibits, Financial Statement Schedules
|
|
|
Item 16.
|
Form 10-K Summary
|
|
|
SIGNATURES
|
||
|
•
|
The HVE-STACK high density server provides the computer and storage appliance for the data center and is ideal for high performance computing (“HPC”), cloud computing and virtual desktop infrastructure (“VDI”). The modular design and swappable components include hard drives and power supplies intended to improve the efficiency of data center deployment.
|
|
•
|
The HVE-VELOCITY High Availability Dual Enclosure storage area network (“SAN”) provides data reliability and integrity for optimal data storage, protection and recovery. It also provides a unified network attached storage (“NAS”) and SAN solution with thin provisioning, compression and deduplication. The HVE-VELOCITY platform is designed to eliminate single points of failure. The 12GSAS SSD design allows for faster access to data. It is optimized for mission-critical, enterprise-level storage applications.
|
|
•
|
The HVE 3DGFX is a VDI solution that offers hardware and software technologies to provide an appliance that can handle from eight to up to 128 high demand users in a single 2U appliance. The HVE 3DGFX was designed and engineered as a purpose-built solution based upon the MSRP engineering approach.
|
|
•
|
The SnapServer
®
XSR40 is a 1U server that can be configured with up to four SATA III and SSD drives, and can scale to 400 TB of storage capacity by adding up to three SnapExpansion XSR
™
enclosures.
|
|
•
|
The SnapServer
®
XSR120 is a 2U server that can be configured with up to 12 SATA III, SAS and SSD drives, and can scale to 960 TB of storage capacity by adding up to seven SnapExpansion XSR
™
enclosures.
|
|
•
|
Disk Systems - RDX
®
Removable Disk Solutions
|
|
•
|
Tape Automation Systems - NEO
®
Tape-Based Backup and Long-Term Archive Solutions
|
|
•
|
Tape Drives and Media
|
|
•
|
Distribution channel
-
We have distribution partners in North America. We sell through a two-tier distribution model where distributors sell our products to system integrators, VARs or DMRs, who in turn sell to end users. We support these distribution partners through our dedicated sales force and engineers. In 2018, two distribution partners accounted for, in the aggregate, 25.4% of net revenue.
|
|
•
|
Reseller channel
-
Our worldwide reseller channel includes systems integrators, VARs and DMRs. Our resellers may package our products as part of complete application and desktop virtualization solutions data processing systems or with other storage devices to deliver complete enterprise information technology infrastructure solutions. Our resellers also recommend our products as replacement solutions when systems are upgraded, or bundle our products with storage management software specific to the end user’s system. We support the reseller channel through our dedicated sales representatives, engineers and technical support organizations.
|
|
•
|
Cloud Marketplace
-
Since 2015, we have utilized the Microsoft Azure Cloud Marketplace as an additional channel for our cloud solutions to sell to end-users directly with the pay-per-use model, supported through the Microsoft Azure Cloud.
|
|
•
|
build or leverage, as applicable, a network of channel partners to create an expanding presence in the evolving marketplace for our products and services;
|
|
•
|
build or leverage, as applicable, a sales team to keep end-users and channel partners informed regarding the technical features, issues and key selling points of our products and services;
|
|
•
|
attract and retain qualified technical personnel in order to continue to develop reliable and flexible products and provide services that respond to evolving customer needs;
|
|
•
|
develop support capacity for end-users as sales increase, so that we can provide post-sales support without diverting resources from product development efforts; and
|
|
•
|
expand our internal management and financial controls significantly, so that we can maintain control over our operations and provide support to other functional areas as the number of personnel and size increases.
|
|
•
|
varying size, timing and contractual terms of orders for our products, which may delay the recognition of revenue;
|
|
•
|
competitive conditions in the industry, including strategic initiatives by us or our competitors, new products or services, product or service announcements and changes in pricing policy by us or our competitors;
|
|
•
|
market acceptance of our products and services;
|
|
•
|
our ability to maintain existing relationships and to create new relationships with channel partners;
|
|
•
|
the discretionary nature of purchase and budget cycles of our customers and end-users;
|
|
•
|
the length and variability of the sales cycles for our products;
|
|
•
|
general weakening of the economy resulting in a decrease in the overall demand for our products and services or otherwise affecting the capital investment levels of businesses with respect to our products or services;
|
|
•
|
timing of product development and new product initiatives;
|
|
•
|
changes in customer mix;
|
|
•
|
increases in the cost of, or limitations on, the availability of materials;
|
|
•
|
fluctuations in average selling prices;
|
|
•
|
changes in product mix; and
|
|
•
|
increases in costs and expenses associated with the introduction of new products.
|
|
•
|
a change in competitive strategy that adversely affects a distributor’s or reseller’s willingness or ability to stock and distribute our products;
|
|
•
|
the reduction, delay or cancellation of orders or the return of a significant amount of our products;
|
|
•
|
the loss of one or more of our distributors or resellers; and
|
|
•
|
any financial difficulties of our distributors or resellers that result in their inability to pay amounts owed to us.
|
|
•
|
diversion of management’s attention;
|
|
•
|
disruption to our ongoing business;
|
|
•
|
failure to retain key acquired personnel;
|
|
•
|
difficulties in integrating acquired operations, technologies, products or personnel;
|
|
•
|
unanticipated expenses, events or circumstances;
|
|
•
|
assumption of disclosed and undisclosed liabilities; and
|
|
•
|
inappropriate valuation of the acquired in-process research and development, or the entire acquired business.
|
|
•
|
divert the attention of our management, cause significant delays, materially disrupt the conduct of our business or materially adversely affect our revenue, financial condition and results of operations;
|
|
•
|
be time consuming to evaluate and defend;
|
|
•
|
result in costly litigation and substantial expenses;
|
|
•
|
cause product shipment delays or stoppages;
|
|
•
|
subject us to significant liabilities;
|
|
•
|
require us to enter into costly royalty or licensing agreements;
|
|
•
|
require us to modify or stop using the infringing technology; or
|
|
•
|
result in costs or other consequences that have a material adverse effect on our business, results of operations and financial condition.
|
|
•
|
price and volume fluctuations in the overall stock market from time to time;
|
|
•
|
volatility in the market prices and trading volumes of technology stocks;
|
|
•
|
changes in operating performance and stock market valuations of other technology companies generally, or those in our industry in particular;
|
|
•
|
future capital raising activities;
|
|
•
|
sales of common shares by holders thereof or by us;
|
|
•
|
failure of securities analysts to maintain coverage of Sphere 3D, changes in financial estimates by securities analysts who follow Sphere 3D, or our failure to meet these estimates or the expectations of investors;
|
|
•
|
the financial projections we may provide to the public, any changes in those projections or our failure to meet those projections;
|
|
•
|
market acceptance of our products and technologies;
|
|
•
|
announcements by us or our competitors of new products or services;
|
|
•
|
the public’s reaction to our press releases, other public announcements and filings with the SEC and the applicable Canadian securities regulatory authorities;
|
|
•
|
rumors and market speculation involving us or other companies in our industry;
|
|
•
|
actual or anticipated changes in our operating results or fluctuations in our operating results;
|
|
•
|
actual or anticipated developments in our business, our competitors’ businesses or the competitive landscape generally;
|
|
•
|
litigation involving us, our industry or both, or investigations by regulators into our operations or those of our competitors;
|
|
•
|
developments or disputes concerning our intellectual property or other proprietary rights;
|
|
•
|
announced or completed acquisitions of businesses or technologies by us or our competitors;
|
|
•
|
new laws or regulations or new interpretations of existing laws or regulations applicable to us and our business;
|
|
•
|
changes in accounting standards, policies, guidelines, interpretations or principles;
|
|
•
|
any significant change in our executive officers and other key personnel or Board of Directors;
|
|
•
|
general economic conditions and slow or negative growth of our markets;
|
|
•
|
release of transfer restrictions on certain outstanding common shares; and
|
|
•
|
news reports relating to trends, concerns or competitive developments, regulatory changes and other related issues in our industry or target markets.
|
|
|
|
2018
|
|
2017
|
||||
|
|
|
High
|
|
Low
|
|
High
|
|
Low
|
|
First Quarter
|
|
$24.32
|
|
$7.00
|
|
$112.00
|
|
$40.20
|
|
Second Quarter
|
|
$9.12
|
|
$2.56
|
|
$58.00
|
|
$22.00
|
|
Third Quarter
|
|
$5.76
|
|
$1.06
|
|
$52.80
|
|
$17.05
|
|
Fourth Quarter
|
|
$8.70
|
|
$1.52
|
|
$31.60
|
|
$15.20
|
|
•
|
On November 14, 2018, the Board of Directors of the Company appointed Peter Tassiopoulos to serve as the Company’s Chief Executive Officer and Principal Executive Officer. The appointment decision was made in connection with the Company’s completion of the sale of Overland. As a result of such appointment, Eric Kelly ceased to serve as the Company’s Chief Executive Officer and no longer holds any positions with the Company. On November 14, 2018, the Board of Directors of the Company appointed Joseph O’Daniel as President of the Company, to succeed Mr. Tassiopoulos in such position.
|
|
•
|
On November 12, 2018, we received a letter from the Nasdaq Listing Qualifications department of The Nasdaq Stock Market LLC notifying us that we were not in compliance with the requirement of Nasdaq Marketplace Rule 5550(b)(1) for continued inclusion on the NASDAQ Capital Market because the Company’s stockholders’ equity of $707,000 reported in the Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2018, is below the required minimum of $2.5 million.
|
|
|
Year Ended December 31,
|
||||
|
|
2018
|
|
2017
|
||
|
Net revenue
|
100.0
|
%
|
|
100.0
|
%
|
|
Cost of revenue
|
81.4
|
|
|
75.0
|
|
|
Gross profit
|
18.6
|
|
|
25.0
|
|
|
Operating expenses:
|
|
|
|
||
|
Sales and marketing
|
37.4
|
|
|
27.0
|
|
|
Research and development
|
37.9
|
|
|
46.6
|
|
|
General and administrative
|
83.0
|
|
|
76.6
|
|
|
Impairment of acquired intangible assets
|
—
|
|
|
18.2
|
|
|
|
158.3
|
|
|
168.4
|
|
|
Loss from operations
|
(139.7
|
)
|
|
(143.4
|
)
|
|
Interest expense
|
(0.8
|
)
|
|
—
|
|
|
Other income, net
|
0.1
|
|
|
14.3
|
|
|
Loss before income taxes
|
(140.4
|
)
|
|
(129.1
|
)
|
|
Benefit from income taxes
|
—
|
|
|
(6.8
|
)
|
|
Net loss from continuing operations
|
(140.4
|
)
|
|
(122.3
|
)
|
|
Net loss from discontinued operations
|
(149.7
|
)
|
|
(85.4
|
)
|
|
Net loss
|
(290.1
|
)%
|
|
(207.7
|
)%
|
|
|
Year Ended December 31,
|
|
|
|||||||
|
|
2018
|
|
2017
|
|
Change
|
|||||
|
Disk systems
|
$
|
6,108
|
|
|
$
|
9,698
|
|
|
(37.0
|
)%
|
|
Service
|
2,922
|
|
|
2,901
|
|
|
0.7
|
%
|
||
|
Total
|
$
|
9,030
|
|
|
$
|
12,599
|
|
|
(28.3
|
)%
|
|
|
Year Ended December 31,
|
|
|
|||||||
|
|
2018
|
|
2017
|
|
Change
|
|||||
|
Americas
|
$
|
8,044
|
|
|
$
|
11,121
|
|
|
(27.7
|
)%
|
|
APAC
|
534
|
|
|
823
|
|
|
(35.1
|
)%
|
||
|
EMEA
|
452
|
|
|
655
|
|
|
(31.0
|
)%
|
||
|
Total
|
$
|
9,030
|
|
|
$
|
12,599
|
|
|
(28.3
|
)%
|
|
|
|
Year Ended December 31,
|
|
|
|||||||
|
|
|
2018
|
|
2017
|
|
Change
|
|||||
|
Gross profit
|
|
$
|
1,679
|
|
|
$
|
3,145
|
|
|
(46.6
|
)%
|
|
Gross margin
|
|
18.6
|
%
|
|
25.0
|
%
|
|
(6.4
|
)pt
|
||
|
Gross profit - product
|
|
$
|
627
|
|
|
$
|
1,471
|
|
|
(57.4
|
)%
|
|
Gross margin - product
|
|
10.3
|
%
|
|
15.2
|
%
|
|
(4.9
|
)pt
|
||
|
Gross profit - service
|
|
$
|
1,052
|
|
|
$
|
1,674
|
|
|
(37.2
|
)%
|
|
Gross margin - service
|
|
36.0
|
%
|
|
57.7
|
%
|
|
(21.7
|
)pt
|
||
|
|
|
Year Ended December 31,
|
||||||
|
|
|
2018
|
|
2017
|
||||
|
Net cash used in operating activities
|
|
$
|
(7,621
|
)
|
|
$
|
(8,965
|
)
|
|
Net cash provided by (used in) investing activities
|
|
$
|
944
|
|
|
$
|
(1,174
|
)
|
|
Net cash provided by financing activities
|
|
$
|
2,444
|
|
|
$
|
9,534
|
|
|
Contractual Obligations
|
|
Total
|
|
Less than
1 year
|
|
1-3 years
|
|
3-5 years
|
|
After 5
years
|
||||||||||
|
Series A redeemable preferred shares
|
|
$
|
6,571
|
|
|
$
|
—
|
|
|
$
|
6,571
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Debt
—
related party, including interest
(1)
|
|
503
|
|
|
503
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
Line of credit
|
|
100
|
|
|
100
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
Operating lease obligations
(2)
|
|
346
|
|
|
168
|
|
|
178
|
|
|
—
|
|
|
—
|
|
|||||
|
Purchase obligations
(3)
|
|
546
|
|
|
546
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
Total contractual obligations
|
|
$
|
8,066
|
|
|
$
|
1,317
|
|
|
$
|
6,749
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
(1)
|
Interest payments have been calculated using the amortization profile of the debt outstanding at
December 31, 2018
, taking into account the fixed rate paid at year end.
|
|
(2)
|
Represents contractual lease obligations under non-cancelable operating leases.
|
|
(3)
|
Represents purchase orders for inventory and non-inventory items entered into prior to
December 31, 2018
, with purchase dates extending beyond January 1, 2019. Some of these purchase obligations may be canceled.
|
|
Name
|
|
Age
|
|
Director Since
|
|
Positions with our Company
|
|
|
|
|
|
|
|
|
|
Cheemin Bo-Linn
(1)
|
|
65
|
|
April 17, 2017
|
|
Director, Chair of Audit Committee
|
|
Vivekanand Mahadevan
(1)
|
|
65
|
|
December 1, 2014
|
|
Director, Chair of Nominating and Governance Committee
|
|
Duncan McEwan
(1)
|
|
65
|
|
May 10, 2017
|
|
Director, Chair of Compensation Committee
|
|
Peter Tassiopoulos
|
|
50
|
|
March 7, 2014
|
|
Chief Executive Officer and Director
|
|
Kurt L. Kalbfleisch
|
|
53
|
|
N/A
|
|
Senior Vice President, Chief Financial Officer and Secretary
|
|
Joseph L. O’Daniel
|
|
48
|
|
N/A
|
|
President
|
|
(1)
|
Member of Audit Committee, Compensation Committee and Nominating and Governance Committee.
|
|
Name and Principal Position
|
|
Year
|
|
Salary
($)
|
|
Share- based Awards
($)
|
|
Non-equity Incentive Plan Compensation(1)
($)
|
|
All Other Compensation(2)
($)
|
|
Total Compensation
($)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Peter Tassiopoulos
(3)(4)
|
|
2018
|
|
239,938
|
|
—
|
|
—
|
|
404,831
|
(5)
|
644,769
|
|
Chief Executive Officer
|
|
2017
|
|
237,548
|
|
157,000
|
(6)
|
59,387
|
|
4,643
|
|
458,578
|
|
Eric L. Kelly
(7)
|
|
2018
|
|
364,615
|
|
—
|
|
—
|
|
199,224
|
(8)
|
563,839
|
|
Former Chief Executive Officer
|
|
2017
|
|
400,000
|
|
889,900
|
(9)
|
100,000
|
|
61,718
|
|
1,451,618
|
|
Kurt L. Kalbfleisch
|
|
2018
|
|
300,000
|
|
—
|
|
—
|
|
522,828
|
(10)
|
822,828
|
|
Senior Vice President and
Chief Financial Officer
|
|
2017
|
|
300,000
|
|
478,912
|
(11)
|
45,000
|
|
36,984
|
|
860,896
|
|
Joseph L. O’Daniel
(12)
|
|
2018
|
|
200,000
|
|
181,284
|
(13)
|
—
|
|
11,856
|
|
393,140
|
|
President
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
The amounts shown in the “Non-equity Incentive Plan Compensation” column represent bonuses awarded to the named executive officer for the applicable year under our bonus program in effect for that year.
|
|
(2)
|
The amounts shown in the “All Other Compensation” column reflect amounts we paid on each named executive officers’ behalf for health insurance and life insurance premiums and certain out-of-pocket medical expenses, unless otherwise footnoted.
|
|
(3)
|
As a result of the Overland Divestiture, on November 14, 2018, Mr. Tassiopoulos ceased to serve as the Company’s President and was appointed as the Company’s Chief Executive Officer.
|
|
(4)
|
The dollar amounts reported for Mr. Tassiopoulos in the above table are presented after conversion from Canadian dollars to U.S. dollars. For 2018 and 2017, the average U.S. dollar to Canadian dollar conversion rate in effect was 1.292 and 1.305, respectively.
|
|
(5)
|
This amount includes accrued severance and change of control benefits in the amount of $400,000 that may be payable to Mr. Tassiopoulos under the compensation arrangements described below as a result of the Overland Divestiture. These benefits are being negotiated with Mr. Tassiopoulos and are contingent upon his providing the Company with a general release of all claims.
|
|
(6)
|
This award is a restricted stock unit which was granted on July 10, 2017 and was valued at
$31.40
per share on the grant date (the closing market price for a share of our common stock on that date). Mr. Tassiopoulos irrevocably declined this award subsequent to Board approval.
|
|
(7)
|
As a result of the Overland Divestiture, Mr. Kelly’s employment concluded with the Company effective November 14, 2018.
|
|
(8)
|
This amount includes a negotiated payment of $160,000 in satisfaction of Mr. Kelly’s rights to certain cash payments under the compensation agreements described below as a result of the Overland Divestiture. This amount is being paid over 24 months.
|
|
(9)
|
This amount is comprised of two awards: i) a restricted stock unit for 6,000 shares granted on July 10, 2017 and was valued at
$31.40
per share on the grant date (the closing market price for a share of our common stock on that date); and ii) a restricted stock unit for 35,937 shares granted on December 18, 2017 and was valued at
$19.52
per share on the grant date (the closing market price for a share of our common stock on that date). Mr. Kelly irrevocably declined his restricted stock unit granted on July 10, 2017 subsequent to Board approval.
|
|
(10)
|
This amount includes accrued severance and change of control benefits in the amount of $450,000 that may be payable to Mr. Kalbfleisch under the compensation arrangements described below as a result of the Overland Divestiture. A portion of the accrued severance is expected to be paid by Overland. These benefits are being negotiated with Mr. Kalbfleisch and are contingent upon his providing the Company with a general release of all claims. In addition, this amount includes certain expenses reimbursed by the Company for a vacation that Mr. Kalbfleisch was required to cancel during 2018 and an additional payment by the Company to cover his tax liabilities with respect to these reimbursed expenses.
|
|
(11)
|
This amount is comprised of two awards: i) a restricted stock unit for 4,000 shares granted on July 10, 2017 and was valued at
$31.40
per share on the grant date (the closing market price for a share of our common stock on that date); and ii) a restricted stock unit for 18,100 shares granted on December 18, 2017 and was valued at
$19.52
per share on the grant date (the closing market price for a share of our common stock on that date).
|
|
(12)
|
Mr. O’Daniel was appointed as the Company’s President on November 14, 2018.
|
|
(13)
|
This is a restricted stock award which was granted on February 20, 2018 and was valued at $18.72 per share on the grant date (the closing market price for a share of our common stock on that date).
|
|
Name
|
|
|
|
Option-based Awards
|
|
Stock Awards
|
||||||||||||||||
|
|
Grant Date
|
|
Number of Securities
Underlying
Unexercised Options (#)
|
Number of Securities
Underlying
Unexercised Options (#)
|
|
Option Exercise Price(1)
($)
|
Option Expiration Date
|
|
Number of Units
of Stock Not Vested (#)
|
|
Market Value of Units of
Stock Not Vested(2)
($)
|
|||||||||||
|
|
Exercisable
|
Unexercisable
|
|
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Peter Tassiopoulos
|
|
9/16/2013
|
|
500
|
|
|
—
|
|
|
|
414.86
|
|
|
9/15/2023
|
|
|
—
|
|
|
|
—
|
|
|
Eric L. Kelly
|
|
7/9/2013
|
|
4,250
|
|
|
—
|
|
|
|
100.62
|
|
|
7/8/2023
|
|
(3)
|
—
|
|
|
|
—
|
|
|
|
|
9/16/2013
|
|
125
|
|
|
—
|
|
|
|
414.86
|
|
|
9/15/2023
|
|
(3)
|
—
|
|
|
|
—
|
|
|
|
|
8/26/2015
|
|
700
|
|
|
—
|
|
|
|
542.00
|
|
|
8/26/2021
|
|
(3)
|
—
|
|
|
|
—
|
|
|
|
|
12/18/2017
|
|
|
|
|
|
|
|
|
|
|
29,947
|
|
(4)
|
|
91,338
|
|
||||
|
Kurt L. Kalbfleisch
|
|
8/26/2015
|
|
500
|
|
|
—
|
|
|
|
542.00
|
|
|
8/26/2021
|
|
|
—
|
|
|
|
—
|
|
|
|
|
12/18/2017
|
|
—
|
|
|
—
|
|
|
|
—
|
|
|
—
|
|
|
12,066
|
|
(5)
|
|
36,801
|
|
|
(1)
|
The exercise prices reported for the options expiring in 2023 for Messrs. Kelly and Tassiopoulos in the table above are presented after conversion from Canadian dollars to U.S. dollars based on an exchange rate of 1.292 Canadian dollars to one U.S. dollar, which is the average conversion rate in effect for 2018.
|
|
(2)
|
Computed by multiplying the number of unvested shares by $3.05, the closing market price of our common shares on
December 31, 2018
.
|
|
(3)
|
These options were cancelled on February 14, 2019 due to Mr. Kelly’s termination of employment on November 14, 2018. Under the option agreements, Mr. Kelly had three months from his termination date to exercise his vested options.
|
|
(4)
|
These shares were subject to accelerated vesting pursuant to the terms of the RSU agreement as a result of the Overland Divestiture; however, acceleration of these shares was contingent upon Mr. Kelly providing us with a general release of all claims. Mr. Kelly provided the Company with a signed release in February 2019, at which time the shares vested and were released to Mr. Kelly.
|
|
(5)
|
This stock award is scheduled to vest in bi-annual installments beginning on June 18, 2019 and ending on December 18, 2020. These shares are subject to accelerated vesting pursuant to the terms of the RSU agreement as a result of the Overland Divestiture; however, acceleration of these shares is being negotiated with Mr. Kalbfleisch and is subject to his providing us with a general release of all claims.
|
|
Name
|
|
Fees Earned
($)
|
|
Stock Awards(1)
($)
|
|
All Other Compensation
($)
|
|
Total
($)
|
|
|
|
|
|
|
|
|
|
|
|
Cheemin Bo-Linn
|
|
135,000
|
|
12,367
|
(2)
|
—
|
|
147,365
|
|
Vivekanand Mahadevan
|
|
135,000
|
|
12,367
|
(2)
|
—
|
|
147,365
|
|
Duncan McEwan
|
|
125,000
|
|
12,367
|
(2)
|
—
|
|
137,365
|
|
(1)
|
At the end of fiscal 2018, our non-employee directors did not have any outstanding equity awards.
|
|
(2)
|
These amounts are comprised of two awards: i) a stock award for 561 shares granted on March 28, 2018 and was valued at $7.92 per share on the grant date (the closing market price for a share of our common stock on that date); and ii) a stock award for 1,981 shares granted on May 8, 2018 and was valued at $4.00 per share on the grant date (the closing market price for a share of our common stock on that date). The stock awards were fully vested on grant and paid in lieu of cash for fees associated with services on the Special Committee as described below.
|
|
Plan Category
|
|
(a)
Number of
Common Shares
to be Issued
Upon Exercise
of Outstanding
Options and Rights
|
|
(b)
Weighted-average
Exercise Price
of Outstanding
Options and
Rights
(1)
|
|
(c)
Number of Common
Shares Remaining
Available for Future
Issuance Under
Equity Compensation
Plans (Excluding
Shares Reflected
in Column (a))
|
||
|
|
|
|
|
|
|
|
||
|
Equity compensation plans approved by our shareholders
(2)
|
|
71,404
|
|
|
$322.57
|
|
179,956
|
|
|
Equity compensation plans not approved by our shareholders
(3)
|
|
1,650
|
|
|
—
|
|
—
|
|
|
Total
|
|
73,054
|
|
|
|
|
179,956
|
|
|
(1)
|
The weighted-average exercise prices do not reflect shares subject to outstanding awards of restricted stock units.
|
|
(2)
|
Of the aggregate number of shares that are to be issued upon exercise of outstanding options and rights as reported in column (c), 142,456 were available under the 2015 Plan and 37,500 were available under the ESPP. The 2015 Plan permits the granting of the following types of incentive awards: stock options, stock appreciation rights, restricted shares, and stock units.
|
|
(3)
|
These figures represent stock units (the “Inducement Stock Units”) granted to certain employees as an inducement to their commencing employment with us as provided under the Nasdaq listing rules. The Inducement Stock Units are generally subject to the same terms as stock units granted under the 2015 Plan. The Inducement Stock Units vest over three years and are subject to earlier termination in the case of termination of the employee’s employment or a change in control of the Company.
|
|
Beneficial Owner
(1)
|
|
Number of Shares Beneficially Owned
(2)
|
|
Percent
(3)
|
|
|
|
|
|
|
|
|
|
Cyrus Capital Partners, L.P.
|
|
270,618
|
|
(4)
|
12.0%
|
|
65 East 55 Street, 35th Floor
|
|
|
|
|
|
|
New York, NY 10022
|
|
|
|
|
|
|
MF Ventures, LLC
|
|
226,821
|
|
(5)
|
9.9%
|
|
201 Spear Street, 14
th
Floor
|
|
|
|
|
|
|
San Francisco, CA 94105
|
|
|
|
|
|
|
Peter Tassiopoulos
|
|
1,000
|
|
(6)
|
*
|
|
Eric L. Kelly
|
|
39,745
|
|
(7)
|
1.8%
|
|
Kurt L. Kalbfleisch
|
|
7,902
|
|
(8)
|
*
|
|
Joseph O'Daniel
|
|
10,625
|
|
|
*
|
|
Cheemin Bo-Linn
|
|
4,544
|
|
|
*
|
|
Duncan McEwan
|
|
3,596
|
|
|
*
|
|
Vivekanand Mahadevan
|
|
3,185
|
|
|
*
|
|
Current directors and executive officers as a group (6 persons)
|
|
30,852
|
|
(9)
|
1.4%
|
|
(1)
|
Except as otherwise indicated, the persons named in this table have sole voting and investment power with respect to all common shares shown as beneficially owned by them. Unless otherwise noted, the address for each beneficial owner is: c/o Sphere 3D Corp., 895 Don Mills Road, Bldg.2, Suite 900, Toronto, Ontario, Canada M3C 1W3.
|
|
(2)
|
Under the rules of the Securities and Exchange Commission, a person is deemed to be the beneficial owner of shares that can be acquired by such person within 60 days upon the exercise of options or warrants and vesting of stock awards.
|
|
(3)
|
Calculated on the basis of
2,258,071
shares of common stock outstanding as of
March 20, 2019
, provided that any additional shares of common stock that a stockholder has the right to acquire within 60 days after
March 20, 2019
are deemed to be outstanding for the purpose of calculating that stockholder’s percentage beneficial ownership.
|
|
(4)
|
Information was obtained from Cyrus Capital Partners, L.P. pursuant to Schedule 13D/A filed on EDGAR on November 16, 2018 and Company records. Certain funds and affiliates managed by Cyrus, directly and indirectly own these shares (the “Cyrus Group”). The Cyrus Group is comprised of Cyrus Capital Partners, L.P., a Delaware limited partnership, (“Cyrus”), Crescent 1, L.P., a Delaware limited partnership (“Crescent”), CRS Master Fund, L.P., a Cayman Islands exempted limited partnership, (“CRS”), Cyrus Opportunities Master Fund II, Ltd., a Cayman Islands exempted limited company, (“Cyrus Opportunities)”, Cyrus Select Opportunities Master Fund, Ltd., a Cayman Islands exempted limited company, (“Cyrus Select”), Cyrus Capital Partners GP, L.L.C., a Delaware limited partnership, (“Cyrus GP”), Cyrus Capital Advisors, L.L.C., a Delaware limited liability company, (“Cyrus Advisors”), and Mr. Stephen C. Freidheim. Each of Crescent, CRS, Cyrus Opportunities and Cyrus Select, or collectively the Cyrus Funds, are private investment funds engaged in the business of acquiring, holding and disposing of investments in various companies. Cyrus is the
|
|
(5)
|
Information was obtained from MF Ventures, LLC pursuant to an Early Warning Report filed on SEDAR on March 8, 2019. These shares include the right to acquire
37,500
shares upon exercise of warrants. MF Ventures, LLC is a limited liability company formed to make one or more investments in business ventures or activities deemed appropriate by Victor B. MacFarlane, as Manager of MF Ventures, LLC. Mr. MacFarlane as Manager of MF Ventures, LLC and Thaderine D. MacFarlane as a controlling member of MF Ventures, LLC share voting power over the shares of common stock held by MF Ventures, LLC.
|
|
(6)
|
These shares include the right to acquire shares upon exercise of 500 stock options.
|
|
(7)
|
Information is based upon a Form 4 filed on EDGAR by Mr. Kelly on June 20, 2018, as adjusted for the share consolidation in November 2018, and Company records related to a release of vested RSU shares in February 2019.
|
|
(8)
|
These shares include the right to acquire shares upon exercise of 500 stock options. Does not include the release of restricted stock awards that are eligible for accelerated vesting as a result of the Overland Divestiture. Under the terms of the retention agreement with Mr. Kalbfleisch, unvested restricted stock awards were eligible for accelerated vesting at the closing of the Overland Divestiture, provided he executes a release of claims.
|
|
(9)
|
These shares include the right to acquire shares upon exercise of 1,000 stock options beneficially owned by our executive officers. Does not include release of restricted stock awards that are eligible for accelerated vesting as a result of the Overland Divestiture.
|
|
|
|
2018
|
|
2017
|
||||
|
|
|
|
|
|
||||
|
Audit fees
(1)
|
|
$
|
482
|
|
|
$
|
525
|
|
|
Audit related fees
(2)
|
|
46
|
|
|
59
|
|
||
|
Tax fees
(3)
|
|
30
|
|
|
1
|
|
||
|
All other fees
(4)
|
|
—
|
|
|
—
|
|
||
|
|
|
$
|
558
|
|
|
$
|
585
|
|
|
(1)
|
Audit fees consist of fees billed for professional services rendered in connection with the audit of our annual consolidated financial statements, which were provided in connection with statutory and regulatory filings or engagements.
|
|
(2)
|
Audit-related fees consist of fees billed for assurance and related services that are reasonably related to the performance of the audit or review of our consolidated financial statements, and are not reported under audit fees.
|
|
(3)
|
Tax fees consist of fees billed for professional services rendered for IRS Section 302 net operating loss limitation study.
|
|
(4)
|
All other fees consist of fees for products and services other than the services reported above. There were no such services rendered to us.
|
|
Report of Independent Registered Public Accounting Firm
|
|
|
|
Consolidated Balance Sheets as of December 31, 2018 and 2017
|
|
|
|
Consolidated Statements of Operations for the Years Ended December 31, 2018 and 2017
|
|
|
|
Consolidated Statements of Comprehensive Loss for the Years Ended December 31, 2018 and 2017
|
|
|
|
Consolidated Statements of Cash Flows for the Years Ended December 31, 2018 and 2017
|
|
|
|
Consolidated Statements of Shareholders' Equity (Deficit) for the Years Ended December 31, 2018 and 2017
|
|
|
|
Notes to Consolidated Financial Statements
|
|
|
|
Exhibit
|
|
Filed
|
Incorporated by Reference
|
||
|
Number
|
Description
|
Herewith
|
Form
|
File No.
|
Date Filed
|
|
|
|
|
|
|
|
|
1.1
|
|
8-K
|
001-36532
|
4/17/2018
|
|
|
|
|
|
|
|
|
|
2.1*
|
|
8-K
|
001-36532
|
2/21/2018
|
|
|
|
|
|
|
|
|
|
2.2
|
|
8-K
|
001-36532
|
8/21/2018
|
|
|
|
|
|
|
|
|
|
2.3
|
|
8-K
|
001-36532
|
11/2/2018
|
|
|
|
|
|
|
|
|
|
3.1
|
|
6-K
|
001-36532
|
3/25/2015
|
|
|
|
|
|
|
|
|
|
3.2
|
|
6-K
|
001-36532
|
7/17/2017
|
|
|
|
|
|
|
|
|
|
3.3
|
|
8-K
|
001-36532
|
10/2/2018
|
|
|
|
|
|
|
|
|
|
3.4
|
|
8-K
|
001-36532
|
11/5/2018
|
|
|
|
|
|
|
|
|
|
3.5
|
|
8-K
|
001-36532
|
11/14/2018
|
|
|
|
|
|
|
|
|
|
3.6
|
|
6-K
|
001-36532
|
7/17/2017
|
|
|
|
|
|
|
|
|
|
3.7
|
|
6-K
|
001-36532
|
5/12/2017
|
|
|
|
|
|
|
|
|
|
4.1
|
|
F-3
|
333-210735
|
4/13/2016
|
|
|
|
|
|
|
|
|
|
4.2
|
|
6-K
|
001-36532
|
6/2/2015
|
|
|
|
|
|
|
|
|
|
4.3
|
|
6-K
|
001-36532
|
10/7/2015
|
|
|
|
|
|
|
|
|
|
4.4
|
|
6-K
|
001-36532
|
8/15/2017
|
|
|
|
|
|
|
|
|
|
4.5
|
|
8-K
|
001-36532
|
4/17/2018
|
|
|
|
|
|
|
|
|
|
10.1
|
|
6-K
|
001-36532
|
12/16/2014
|
|
|
|
|
|
|
|
|
|
10.2
|
|
6-K
|
001-36532
|
12/2/2015
|
|
|
|
|
|
|
|
|
|
10.3
|
|
6-K
|
001-36532
|
4/7/2016
|
|
|
|
|
|
|
|
|
|
Exhibit
|
|
Filed
|
Incorporated by Reference
|
||
|
Number
|
Description
|
Herewith
|
Form
|
File No.
|
Date Filed
|
|
10.4
|
|
10-Q
|
001-36532
|
5/10/2018
|
|
|
|
|
|
|
|
|
|
10.5
|
|
10-Q
|
001-36532
|
8/14/2018
|
|
|
|
|
|
|
|
|
|
10.6
|
|
10-Q
|
001-36532
|
8/14/2018
|
|
|
|
|
|
|
|
|
|
10.7
|
|
10-Q
|
001-36532
|
8/14/2018
|
|
|
|
|
|
|
|
|
|
10.8
|
|
10-Q
|
001-36532
|
8/14/2018
|
|
|
|
|
|
|
|
|
|
10.9
|
|
10-Q
|
001-36532
|
8/14/2018
|
|
|
|
|
|
|
|
|
|
10.10
|
|
10-Q
|
001-36532
|
8/14/2018
|
|
|
|
|
|
|
|
|
|
10.11
|
|
6-K
|
001-36532
|
6/2/2015
|
|
|
|
|
|
|
|
|
|
10.12
|
|
6-K
|
001-36532
|
10/7/2015
|
|
|
|
|
|
|
|
|
|
10.13
|
|
8-K
|
001-36532
|
11/14/2018
|
|
|
|
|
|
|
|
|
|
10.14
|
|
8-K
|
001-36532
|
11/14/2018
|
|
|
|
|
|
|
|
|
|
10.15
|
|
8-K
|
001-36532
|
11/14/2018
|
|
|
|
|
|
|
|
|
|
10.16
|
|
8-K
|
001-36532
|
11/14/2018
|
|
|
|
|
|
|
|
|
|
10.17
|
|
8-K
|
001-36532
|
11/14/2018
|
|
|
|
|
|
|
|
|
|
10.18
|
|
8-K
|
001-36532
|
11/14/2018
|
|
|
|
|
|
|
|
|
|
10.19
|
|
F-4
|
333-197569
|
7/23/2014
|
|
|
|
|
|
|
|
|
|
10.20
|
|
S-8
|
333-214605
|
11/14/2018
|
|
|
|
|
|
|
|
|
|
10.21
|
|
S-8
|
333-209251
|
2/1/2016
|
|
|
|
|
|
|
|
|
|
Exhibit
|
|
Filed
|
Incorporated by Reference
|
||
|
Number
|
Description
|
Herewith
|
Form
|
File No.
|
Date Filed
|
|
10.22
|
|
S-8
|
333-209251
|
2/1/2016
|
|
|
|
|
|
|
|
|
|
10.23
|
|
S-8
|
333-205236
|
1/29/2018
|
|
|
|
|
|
|
|
|
|
10.24+
|
|
8-K
|
000-22071
|
8/4/2011
|
|
|
|
|
|
|
|
|
|
10.25+
|
|
10-K
|
001-36532
|
3/21/2018
|
|
|
|
|
|
|
|
|
|
10.26+
|
|
10-K
|
001-36532
|
3/21/2018
|
|
|
|
|
|
|
|
|
|
10.27+
|
|
10-K
|
001-36532
|
3/21/2018
|
|
|
|
|
|
|
|
|
|
10.28+
|
|
10-K
|
001-36532
|
3/21/2018
|
|
|
|
|
|
|
|
|
|
10.29+
|
|
10-K
|
001-36532
|
3/21/2018
|
|
|
|
|
|
|
|
|
|
10.30+
|
|
10-K
|
001-36532
|
3/21/2018
|
|
|
|
|
|
|
|
|
|
10.31+
|
|
10-K
|
001-36532
|
3/21/2018
|
|
|
|
|
|
|
|
|
|
10.32
|
|
10-K
|
001-36532
|
3/21/2018
|
|
|
|
|
|
|
|
|
|
10.33+
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
10.34
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
10.35+
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
10.36
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
10.37
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
14.1
|
|
6-K
|
001-36532
|
4/1/2015
|
|
|
|
|
|
|
|
|
|
21.1
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
23.1
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
31.1
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit
|
|
Filed
|
Incorporated by Reference
|
||
|
Number
|
Description
|
Herewith
|
Form
|
File No.
|
Date Filed
|
|
31.2
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
32.1
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
32.2
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
101.INS
|
XBRL Instance Document
|
X
|
|
|
|
|
|
|
|
|
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema
|
X
|
|
|
|
|
|
|
|
|
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase
|
X
|
|
|
|
|
|
|
|
|
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase
|
X
|
|
|
|
|
|
|
|
|
|
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase
|
X
|
|
|
|
|
|
|
|
|
|
|
|
101.PRE
|
XBRL Taxonomy Presentation Linkbase
|
X
|
|
|
|
|
Sphere 3D Corp.
|
|
|
|
/s/ Peter Tassiopoulos
|
|
Peter Tassiopoulos
|
|
Chief Executive Officer
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
|
/s/ P
ETER
T
ASSIOPOULOS
|
|
Chief Executive Officer (Principal Executive Officer)
|
|
March 29, 2019
|
|
Peter Tassiopoulos
|
|
|
|
|
|
|
|
|
|
|
|
/s/ K
URT
L. K
ALBFLEISCH
|
|
Chief Financial Officer (Principal Financial and Accounting Officer)
|
|
March 29, 2019
|
|
Kurt L. Kalbfleisch
|
|
|
|
|
|
|
|
|
|
|
|
/s/ C
HEEMIN
B
O-
L
INN
|
|
Director
|
|
March 29, 2019
|
|
Cheemin Bo-Linn
|
|
|
|
|
|
|
|
|
|
|
|
/s/ V
IVEKANAND
M
AHADEVAN
|
|
Director
|
|
March 29, 2019
|
|
Vivekanand Mahadevan
|
|
|
|
|
|
|
|
|
|
|
|
/s/ D
UNCAN
M
C
E
WAN
|
|
Director
|
|
March 29, 2019
|
|
Duncan McEwan
|
|
|
|
|
|
|
December 31, 2018
|
|
December 31, 2017
|
||||
|
Assets
|
|
|
|
||||
|
Current assets:
|
|
|
|
||||
|
Cash and cash equivalents
|
$
|
341
|
|
|
$
|
600
|
|
|
Accounts receivable, net
|
1,142
|
|
|
1,911
|
|
||
|
Inventories
|
1,230
|
|
|
1,449
|
|
||
|
Other current assets
|
784
|
|
|
418
|
|
||
|
Assets of discontinued operations
|
—
|
|
|
72,009
|
|
||
|
Total current assets
|
3,497
|
|
|
76,387
|
|
||
|
Investment in affiliate
|
2,100
|
|
|
—
|
|
||
|
Property and equipment, net
|
6
|
|
|
24
|
|
||
|
Intangible assets, net
|
3,348
|
|
|
5,198
|
|
||
|
Goodwill
|
1,385
|
|
|
1,385
|
|
||
|
Other assets
|
950
|
|
|
286
|
|
||
|
Total assets
|
$
|
11,286
|
|
|
$
|
83,280
|
|
|
Liabilities and Shareholders’ (Deficit) Equity
|
|
|
|
||||
|
Current liabilities:
|
|
|
|
||||
|
Accounts payable
|
$
|
4,600
|
|
|
$
|
3,079
|
|
|
Accrued liabilities
|
1,711
|
|
|
1,261
|
|
||
|
Accrued payroll and employee compensation
|
1,717
|
|
|
1,319
|
|
||
|
Deferred revenue
|
988
|
|
|
1,119
|
|
||
|
Debt, related party
|
500
|
|
|
—
|
|
||
|
Line of credit
|
100
|
|
|
—
|
|
||
|
Other current liabilities
|
23
|
|
|
22
|
|
||
|
Liabilities of discontinued operations
|
—
|
|
|
63,780
|
|
||
|
Total current liabilities
|
9,639
|
|
|
70,580
|
|
||
|
Series A redeemable preferred shares
|
6,571
|
|
|
—
|
|
||
|
Deferred revenue, long-term
|
667
|
|
|
552
|
|
||
|
Deferred income taxes
|
16
|
|
|
16
|
|
||
|
Other non-current liabilities
|
—
|
|
|
1,669
|
|
||
|
Total liabilities
|
16,893
|
|
|
72,817
|
|
||
|
Commitments and contingencies (Note 17)
|
|
|
|
|
|
||
|
Shareholders’ (deficit) equity:
|
|
|
|
||||
|
Common shares, no par value; 2,219,141 and 889,461 shares issued and outstanding as of December 31, 2018 and 2017, respectively
|
183,524
|
|
|
173,871
|
|
||
|
Accumulated other comprehensive loss
|
(1,816
|
)
|
|
(1,981
|
)
|
||
|
Accumulated deficit
|
(187,315
|
)
|
|
(161,427
|
)
|
||
|
Total shareholders’ (deficit) equity
|
(5,607
|
)
|
|
10,463
|
|
||
|
Total liabilities and shareholders’ (deficit) equity
|
$
|
11,286
|
|
|
$
|
83,280
|
|
|
|
Year Ended December 31,
|
||||||
|
|
2018
|
|
2017
|
||||
|
Net revenue:
|
|
|
|
||||
|
Product revenue
|
$
|
6,108
|
|
|
$
|
9,698
|
|
|
Service revenue
|
2,922
|
|
|
2,901
|
|
||
|
|
9,030
|
|
|
12,599
|
|
||
|
Cost of product revenue
|
5,481
|
|
|
8,227
|
|
||
|
Cost of service revenue
|
1,870
|
|
|
1,227
|
|
||
|
Gross profit
|
1,679
|
|
|
3,145
|
|
||
|
Operating expenses:
|
|
|
|
||||
|
Sales and marketing
|
3,375
|
|
|
3,402
|
|
||
|
Research and development
|
3,425
|
|
|
5,867
|
|
||
|
General and administrative
|
7,499
|
|
|
9,653
|
|
||
|
Impairment of acquired intangible assets
|
—
|
|
|
2,294
|
|
||
|
|
14,299
|
|
|
21,216
|
|
||
|
Loss from operations
|
(12,620
|
)
|
|
(18,071
|
)
|
||
|
Other income (expense):
|
|
|
|
||||
|
Interest expense, related party
|
(76
|
)
|
|
—
|
|
||
|
Other income, net
|
10
|
|
|
1,799
|
|
||
|
Loss before income taxes
|
(12,686
|
)
|
|
(16,272
|
)
|
||
|
Benefit from income taxes
|
—
|
|
|
(852
|
)
|
||
|
Net loss from continuing operations
|
(12,686
|
)
|
|
(15,420
|
)
|
||
|
Net loss from discontinued operations
|
(13,522
|
)
|
|
(10,764
|
)
|
||
|
Net loss
|
$
|
(26,208
|
)
|
|
$
|
(26,184
|
)
|
|
Net loss per share:
|
|
|
|
||||
|
Continuing operations
|
$
|
(7.65
|
)
|
|
$
|
(24.78
|
)
|
|
Discontinued operations
|
(8.15
|
)
|
|
(17.30
|
)
|
||
|
Net loss per share basic and diluted
|
$
|
(15.80
|
)
|
|
$
|
(42.08
|
)
|
|
Shares used in computing net loss per share:
|
|
|
|
||||
|
Basic and diluted
|
1,658,862
|
|
|
622,203
|
|
||
|
|
Year Ended December 31,
|
||||||
|
|
2018
|
|
2017
|
||||
|
Net loss
|
$
|
(26,208
|
)
|
|
$
|
(26,184
|
)
|
|
Other comprehensive income (loss):
|
|
|
|
||||
|
Foreign currency translation adjustment
|
34
|
|
|
(416
|
)
|
||
|
Foreign currency reclassification to discontinued operations
|
131
|
|
|
—
|
|
||
|
Total other comprehensive income (loss)
|
165
|
|
|
(416
|
)
|
||
|
Comprehensive loss
|
$
|
(26,043
|
)
|
|
$
|
(26,600
|
)
|
|
|
Year Ended December 31,
|
||||||
|
|
2018
|
|
2017
|
||||
|
Operating activities:
|
|
|
|
||||
|
Net loss
|
$
|
(26,208
|
)
|
|
$
|
(26,184
|
)
|
|
Adjustments to reconcile net loss to cash used in operating activities:
|
|
|
|
||||
|
Loss on disposal of discontinued operations
|
4,281
|
|
|
—
|
|
||
|
Impairment of acquired intangible assets
|
—
|
|
|
2,524
|
|
||
|
Depreciation and amortization
|
3,857
|
|
|
6,087
|
|
||
|
Share-based compensation
|
1,637
|
|
|
7,795
|
|
||
|
Provision for losses on accounts receivable
|
88
|
|
|
12
|
|
||
|
Amortization of debt issuance costs
|
1,532
|
|
|
2,241
|
|
||
|
Fair value adjustment of warrants
|
(259
|
)
|
|
(2,249
|
)
|
||
|
Payment in-kind interest expense, related party
|
875
|
|
|
15
|
|
||
|
Deferred tax benefit
|
—
|
|
|
(2,114
|
)
|
||
|
Loss on revaluation of investment
|
—
|
|
|
1,145
|
|
||
|
Changes in operating assets and liabilities
(net of effects of acquisition)
:
|
|
|
|
||||
|
Accounts receivable
|
2,867
|
|
|
1,377
|
|
||
|
Inventories
|
645
|
|
|
2,048
|
|
||
|
Accounts payable and accrued liabilities
|
7,076
|
|
|
1,398
|
|
||
|
Accrued payroll and employee compensation
|
(933
|
)
|
|
785
|
|
||
|
Deferred revenue
|
(1,221
|
)
|
|
(808
|
)
|
||
|
Other assets and liabilities, net
|
(1,858
|
)
|
|
(3,037
|
)
|
||
|
Net cash used in operating activities
|
(7,621
|
)
|
|
(8,965
|
)
|
||
|
Investing activities:
|
|
|
|
||||
|
Proceeds from divestiture
|
1,000
|
|
|
—
|
|
||
|
Acquisition, net of cash acquired
|
—
|
|
|
(1,051
|
)
|
||
|
Purchase of fixed assets
|
(56
|
)
|
|
(123
|
)
|
||
|
Net cash provided by (used in) investing activities
|
944
|
|
|
(1,174
|
)
|
||
|
Financing activities:
|
|
|
|
||||
|
Proceeds from issuance of common shares and warrants
|
2,310
|
|
|
10,862
|
|
||
|
Payment for issuance costs
|
(421
|
)
|
|
(1,020
|
)
|
||
|
Proceeds from debt, related party
|
500
|
|
|
2,000
|
|
||
|
Payments on debt, related party
|
(192
|
)
|
|
(2,308
|
)
|
||
|
Proceeds from exercise of outstanding warrants
|
147
|
|
|
—
|
|
||
|
Proceeds from line of credit
|
100
|
|
|
—
|
|
||
|
Net cash provided by financing activities
|
2,444
|
|
|
9,534
|
|
||
|
Effect of exchange rate changes on cash
|
(24
|
)
|
|
147
|
|
||
|
Net decrease in cash and cash equivalents
|
(4,257
|
)
|
|
(458
|
)
|
||
|
Cash and cash equivalents, beginning of period
|
4,598
|
|
|
5,056
|
|
||
|
Cash and cash equivalents, end of period
|
341
|
|
|
4,598
|
|
||
|
Less: Cash and cash equivalents, discontinued operations
|
—
|
|
|
3,998
|
|
||
|
Cash and cash equivalents of continuing operations, end of period
|
$
|
341
|
|
|
$
|
600
|
|
|
|
Year Ended December 31,
|
||||||
|
|
2018
|
|
2017
|
||||
|
Supplemental disclosures of cash flow information:
|
|
|
|
||||
|
Cash paid for income taxes
|
$
|
1,102
|
|
|
$
|
215
|
|
|
Cash paid for interest
|
$
|
762
|
|
|
$
|
1,681
|
|
|
Supplemental disclosures of non-cash investing and financing activities:
|
|
|
|
||||
|
Conversion of secured debt to Series A redeemable preferred shares
|
$
|
6,500
|
|
|
$
|
—
|
|
|
Issuance of common shares for settlement of liabilities
|
$
|
2,160
|
|
|
$
|
184
|
|
|
Issuance of common shares for related party liabilities
|
$
|
1,393
|
|
|
$
|
1,960
|
|
|
Costs accrued for issuance of common shares
|
$
|
174
|
|
|
$
|
94
|
|
|
Issuance of common shares for acquisition
|
$
|
—
|
|
|
$
|
332
|
|
|
Issuance of warrants in relation to settlement of liabilities
|
$
|
—
|
|
|
$
|
181
|
|
|
|
Common Shares
|
|
Accumulated
Other Comprehensive Loss |
|
Accumulated
Deficit |
|
Total
Shareholders' Equity (Deficit) |
|||||||||||
|
|
Shares
|
|
Amount
|
|
||||||||||||||
|
Balance at January 1, 2017
|
332,988
|
|
|
$
|
157,254
|
|
|
$
|
(1,565
|
)
|
|
$
|
(135,243
|
)
|
|
$
|
20,446
|
|
|
Issuance of common shares and warrants for cash, net
|
233,306
|
|
|
9,993
|
|
|
—
|
|
|
—
|
|
|
9,993
|
|
||||
|
Issuance of common shares for acquisition
|
11,029
|
|
|
332
|
|
|
—
|
|
|
—
|
|
|
332
|
|
||||
|
Issuance of common shares for settlement of related party
interest expense |
73,287
|
|
|
1,960
|
|
|
—
|
|
|
—
|
|
|
1,960
|
|
||||
|
Allocation of warrants to liability
|
—
|
|
|
(3,647
|
)
|
|
—
|
|
|
—
|
|
|
(3,647
|
)
|
||||
|
Issuance of common shares for warrant exchange
|
202,240
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Issuance of common shares pursuant to the vesting of
restricted stock units |
29,694
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Issuance of restricted stock awards
|
6,917
|
|
|
184
|
|
|
—
|
|
|
—
|
|
|
184
|
|
||||
|
Share-based compensation
|
—
|
|
|
7,795
|
|
|
—
|
|
|
—
|
|
|
7,795
|
|
||||
|
Other comprehensive loss
|
—
|
|
|
—
|
|
|
(416
|
)
|
|
—
|
|
|
(416
|
)
|
||||
|
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
(26,184
|
)
|
|
(26,184
|
)
|
||||
|
Balance at December 31, 2017
|
889,461
|
|
|
173,871
|
|
|
(1,981
|
)
|
|
(161,427
|
)
|
|
10,463
|
|
||||
|
Adoption of accounting standards (see note 2)
|
—
|
|
|
—
|
|
|
—
|
|
|
320
|
|
|
320
|
|
||||
|
Issuance of common shares and warrants for cash, net
|
492,600
|
|
|
2,097
|
|
|
—
|
|
|
—
|
|
|
2,097
|
|
||||
|
Exercise of warrants
|
26,250
|
|
|
147
|
|
|
—
|
|
|
—
|
|
|
147
|
|
||||
|
Issuance of common shares for warrant exchange
|
178,875
|
|
|
1,364
|
|
|
—
|
|
|
—
|
|
|
1,364
|
|
||||
|
Issuance of common shares for settlement of related party
interest expense
|
219,434
|
|
|
1,393
|
|
|
—
|
|
|
—
|
|
|
1,393
|
|
||||
|
Issuance of common shares pursuant to the vesting of
restricted stock units
|
71,579
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Issuance of restricted stock awards
|
340,942
|
|
|
2,160
|
|
|
—
|
|
|
—
|
|
|
2,160
|
|
||||
|
Share-based compensation
|
—
|
|
|
2,492
|
|
|
—
|
|
|
—
|
|
|
2,492
|
|
||||
|
Other comprehensive income
|
—
|
|
|
—
|
|
|
165
|
|
|
—
|
|
|
165
|
|
||||
|
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
(26,208
|
)
|
|
(26,208
|
)
|
||||
|
Balance at December 31, 2018
|
2,219,141
|
|
|
$
|
183,524
|
|
|
$
|
(1,816
|
)
|
|
$
|
(187,315
|
)
|
|
$
|
(5,607
|
)
|
|
1.
|
Organization and Business
|
|
2.
|
Significant Accounting Policies
|
|
Furniture and fixtures
|
5 years
|
|
Computer equipment and software
|
1-5 years
|
|
3.
|
Discontinued Operations
|
|
|
|
Year Ended December 31,
|
||||||
|
|
|
2018
|
|
2017
|
||||
|
Revenue of discontinued operations:
|
|
|
|
|
||||
|
Product revenue
|
|
$
|
50,285
|
|
|
$
|
63,122
|
|
|
Service revenue
|
|
4,445
|
|
|
5,803
|
|
||
|
|
|
54,730
|
|
|
68,925
|
|
||
|
Cost of product revenue
|
|
34,493
|
|
|
44,546
|
|
||
|
Cost of service revenue
|
|
1,543
|
|
|
2,471
|
|
||
|
Gross profit of discontinued operations
|
|
18,694
|
|
|
21,908
|
|
||
|
Sales and marketing
|
|
10,987
|
|
|
15,281
|
|
||
|
Research and development
|
|
982
|
|
|
1,783
|
|
||
|
General and administrative
|
|
7,761
|
|
|
10,459
|
|
||
|
Impairment of acquired intangible assets
|
|
—
|
|
|
230
|
|
||
|
|
|
19,730
|
|
|
27,753
|
|
||
|
Loss from operations of discontinued operations
|
|
(1,036
|
)
|
|
(5,845
|
)
|
||
|
Other (expense) income of discontinued operations:
|
|
|
|
|
||||
|
Loss on disposal of discontinued operations
|
|
(4,281
|
)
|
|
—
|
|
||
|
Interest expense, related party
|
|
(3,390
|
)
|
|
(2,520
|
)
|
||
|
Interest expense
|
|
(2,321
|
)
|
|
(3,391
|
)
|
||
|
Other (expense) income
|
|
(920
|
)
|
|
212
|
|
||
|
Loss before income taxes of discontinued operations
|
|
(11,948
|
)
|
|
(11,544
|
)
|
||
|
Provision for (benefit from) income taxes of discontinued operations
|
|
1,574
|
|
|
(780
|
)
|
||
|
Net loss of discontinued operations
|
|
$
|
(13,522
|
)
|
|
$
|
(10,764
|
)
|
|
|
|
December 31,
2017 |
||
|
Assets:
|
|
|
||
|
Cash and cash equivalents
|
|
$
|
3,998
|
|
|
Accounts receivable, net
|
|
9,570
|
|
|
|
Inventories
|
|
6,917
|
|
|
|
Other current assets
|
|
1,411
|
|
|
|
Property and equipment, net
|
|
2,718
|
|
|
|
Intangible assets, net
|
|
36,275
|
|
|
|
Goodwill
|
|
10,205
|
|
|
|
Other assets
|
|
915
|
|
|
|
Total assets of discontinued operations
|
|
$
|
72,009
|
|
|
Liabilities:
|
|
|
||
|
Accounts payable
|
|
$
|
6,283
|
|
|
Accrued liabilities
|
|
4,816
|
|
|
|
Deferred revenue
|
|
4,666
|
|
|
|
Debt, related party
|
|
44,808
|
|
|
|
Other liabilities
|
|
3,207
|
|
|
|
Total liabilities of discontinued operations
|
|
$
|
63,780
|
|
|
|
|
Year Ended December 31,
|
||||||
|
|
|
2018
|
|
2017
|
||||
|
Depreciation and amortization
|
|
$
|
2,137
|
|
|
$
|
2,688
|
|
|
Share-based compensation
|
|
$
|
855
|
|
|
$
|
—
|
|
|
Capital expenditures
|
|
$
|
64
|
|
|
$
|
123
|
|
|
4.
|
Business Combination
|
|
Cash
|
|
$
|
49
|
|
|
Accounts receivable
|
|
582
|
|
|
|
Inventory
|
|
206
|
|
|
|
Identifiable intangible assets
|
|
1,260
|
|
|
|
Other assets
|
|
45
|
|
|
|
Total identifiable assets acquired
|
|
2,142
|
|
|
|
Accounts payable and accrued liabilities
|
|
(359
|
)
|
|
|
Deferred revenue
|
|
(518
|
)
|
|
|
Net identifiable assets acquired
|
|
1,265
|
|
|
|
Goodwill
|
|
522
|
|
|
|
Net assets acquired
|
|
$
|
1,787
|
|
|
|
|
Estimated
Fair Value |
|
Weighted-
Average Useful Life (years) |
||
|
Channel partner relationships
|
|
$
|
730
|
|
|
6.0
|
|
Customer relationships
|
|
380
|
|
|
3.2
|
|
|
Developed technology
|
|
150
|
|
|
3.0
|
|
|
Total identified intangible assets
|
|
$
|
1,260
|
|
|
|
|
5.
|
Investment in Affiliate
|
|
6.
|
Certain Balance Sheet Items
|
|
|
December 31,
|
||||||
|
|
2018
|
|
2017
|
||||
|
Raw materials
|
$
|
255
|
|
|
$
|
84
|
|
|
Work in process
|
282
|
|
|
253
|
|
||
|
Finished goods
|
693
|
|
|
1,112
|
|
||
|
|
$
|
1,230
|
|
|
$
|
1,449
|
|
|
|
December 31,
|
||||||
|
|
2018
|
|
2017
|
||||
|
Deferred cost - service contracts
|
$
|
385
|
|
|
$
|
153
|
|
|
Prepaid insurance and services
|
344
|
|
|
62
|
|
||
|
Other
|
55
|
|
|
203
|
|
||
|
|
$
|
784
|
|
|
$
|
418
|
|
|
|
December 31,
|
||||||
|
|
2018
|
|
2017
|
||||
|
Computer equipment
|
$
|
281
|
|
|
$
|
954
|
|
|
Leasehold improvements
|
—
|
|
|
83
|
|
||
|
Furniture and fixtures
|
—
|
|
|
31
|
|
||
|
|
281
|
|
|
1,068
|
|
||
|
Accumulated depreciation and amortization
|
(275
|
)
|
|
(1,044
|
)
|
||
|
|
$
|
6
|
|
|
$
|
24
|
|
|
|
December 31,
|
||||||
|
|
2018
|
|
2017
|
||||
|
Prepaid Insurance
|
$
|
653
|
|
|
$
|
—
|
|
|
Deferred cost – service contracts
|
270
|
|
|
190
|
|
||
|
Other
|
27
|
|
|
96
|
|
||
|
|
$
|
950
|
|
|
$
|
286
|
|
|
7.
|
Intangible Assets and Goodwill
|
|
|
December 31,
|
||||||
|
|
2018
|
|
2017
|
||||
|
Developed technology
|
$
|
13,383
|
|
|
$
|
13,383
|
|
|
Channel partner relationships
|
730
|
|
|
730
|
|
||
|
Capitalized development costs
(1)
|
2,918
|
|
|
3,166
|
|
||
|
Customer relationships
|
380
|
|
|
380
|
|
||
|
|
17,411
|
|
|
17,659
|
|
||
|
Accumulated amortization:
|
|
|
|
||||
|
Developed technology
|
(12,222
|
)
|
|
(11,145
|
)
|
||
|
Channel partner relationships
|
(233
|
)
|
|
(112
|
)
|
||
|
Capitalized development costs
(1)
|
(1,655
|
)
|
|
(1,409
|
)
|
||
|
Customer relationships
|
(303
|
)
|
|
(145
|
)
|
||
|
|
(14,413
|
)
|
|
(12,811
|
)
|
||
|
Total finite-lived assets, net
|
2,998
|
|
|
4,848
|
|
||
|
Indefinite-lived intangible assets - trade names
|
350
|
|
|
350
|
|
||
|
Total intangible assets, net
|
$
|
3,348
|
|
|
$
|
5,198
|
|
|
(1)
|
Includes the impact of foreign currency exchange rate fluctuations.
|
|
Balance as of January 1, 2017
|
|
$
|
863
|
|
|
Goodwill acquired
|
|
522
|
|
|
|
Balance as of December 31, 2017
|
|
$
|
1,385
|
|
|
8.
|
Debt
|
|
9.
|
Preferred Shares
|
|
10.
|
Fair Value Measurements
|
|
Warrant liability as of January 1, 2017
|
|
$
|
200
|
|
|
Additions to warrant liability
|
|
4,677
|
|
|
|
Change in fair value of warrants
|
|
(2,249
|
)
|
|
|
Reclassification to equity
|
|
(959
|
)
|
|
|
Warrant liability as of December 31, 2017
|
|
1,669
|
|
|
|
Adoption of accounting guidance
|
|
(46
|
)
|
|
|
Change in fair value of warrants
|
|
(259
|
)
|
|
|
Reclassification to equity resulting from warrant exchange agreement
|
|
(1,364
|
)
|
|
|
Warrant liability as of December 31, 2018
|
|
$
|
—
|
|
|
11.
|
Share Capital
|
|
Date issued
|
|
Contractual life (years)
|
|
Exercise price per share
|
|
Number outstanding
|
|
Expiration
|
|
|
May 2015
|
|
5
|
|
$800.00
|
|
4,200
|
|
|
May 31, 2020
|
|
October 2015
|
|
5
|
|
$466.00
|
|
2,010
|
|
|
October 14, 2020
|
|
December 2015
|
|
5
|
|
$500.00
|
|
5,138
|
|
|
December 15, 2020
|
|
December 2015
|
|
5
|
|
$216.00
|
|
7,500
|
|
(1)
|
December 4, 2020
|
|
February 2016
|
|
3
|
|
$324.00
|
|
2,500
|
|
|
February 26, 2019
|
|
March 2016
|
|
5
|
|
$500.00
|
|
150
|
|
|
March 4, 2021
|
|
November 2016
|
|
3
|
|
$400.00
|
|
125
|
|
|
November 8, 2019
|
|
August 2017
|
|
5
|
|
$42.00
|
|
37,500
|
|
|
August 11, 2022
|
|
August 2017
|
|
5
|
|
$42.00
|
|
11,876
|
|
|
August 16, 2022
|
|
August 2017
|
|
5
|
|
$42.00
|
|
25,625
|
|
|
August 22, 2022
|
|
April 2018
|
|
5
|
|
$5.60
|
|
111,563
|
|
|
April 17, 2023
|
|
|
|
|
|
|
|
208,187
|
|
(2)
|
|
|
(1)
|
If the Company or any subsidiary thereof, at any time while this warrant is outstanding, enters into a Variable Rate Transaction (“VRT”) (as defined in the purchase agreement) and the issue price, conversion price or exercise price per share applicable thereto is less than the warrant exercise price then in effect, the exercise price shall be reduced to equal the VRT price.
|
|
(2)
|
Includes
40,000
of warrants to purchase common shares, in the aggregate, outstanding to related parties at
December 31, 2018
.
|
|
12.
|
Equity Incentive Plans
|
|
|
Year Ended December 31,
|
||||
|
|
2018
|
|
2017
|
||
|
Expected volatility
|
—
|
|
|
120.0
|
%
|
|
Risk-free interest rate
|
—
|
|
|
2.1
|
%
|
|
Dividend yield
|
—
|
|
|
—
|
|
|
Expected term (in years)
|
—
|
|
|
4.7
|
|
|
|
|
Shares
|
|
Weighted-
Average
Exercise
Price
|
|
Weighted-
Average
Remaining
Contractual
Term (years)
|
|
Aggregate
Intrinsic
Value
|
|||||
|
Options outstanding at January 1, 2017
|
|
16,258
|
|
|
$
|
434.00
|
|
|
|
|
|
||
|
Granted
|
|
10,924
|
|
|
$
|
31.76
|
|
|
|
|
|
||
|
Exercised
|
|
—
|
|
|
$
|
—
|
|
|
|
|
|
||
|
Forfeited
|
|
(3,646
|
)
|
|
$
|
502.64
|
|
|
|
|
|
||
|
Options outstanding at December 31, 2017
|
|
23,536
|
|
|
$
|
251.20
|
|
|
|
|
|
||
|
Granted
|
|
—
|
|
|
$
|
—
|
|
|
|
|
|
||
|
Exercised
|
|
—
|
|
|
$
|
—
|
|
|
|
|
|
||
|
Forfeited
|
|
(3,486
|
)
|
|
$
|
132.23
|
|
|
|
|
|
||
|
Options outstanding at December 31, 2018
|
|
20,050
|
|
|
$
|
199.06
|
|
|
3.3
|
|
$
|
—
|
|
|
Vested and expected to vest at December 31, 2018
|
|
20,050
|
|
|
$
|
199.06
|
|
|
3.3
|
|
$
|
—
|
|
|
Exercisable at December 31, 2018
|
|
20,028
|
|
|
$
|
199.25
|
|
|
3.3
|
|
$
|
—
|
|
|
|
Year Ended December 31,
|
||||||
|
|
2018
|
|
2017
|
||||
|
Weighted-average grant date fair value per share
|
$
|
—
|
|
|
$
|
25.84
|
|
|
Intrinsic value of options exercised
|
$
|
—
|
|
|
$
|
—
|
|
|
Cash received upon exercise of options
|
$
|
—
|
|
|
$
|
—
|
|
|
|
Number of
Shares
|
|
Weighted Average
Grant Date Fair Value
|
|||
|
Outstanding — January 1, 2017
|
18,948
|
|
|
$
|
516.00
|
|
|
Granted
|
151,405
|
|
|
$
|
31.68
|
|
|
Vested and released
|
(29,694
|
)
|
|
$
|
263.25
|
|
|
Forfeited
|
(14,690
|
)
|
|
$
|
111.12
|
|
|
Outstanding — December 31, 2017
|
125,969
|
|
|
$
|
39.12
|
|
|
Granted
|
50
|
|
|
$
|
20.00
|
|
|
Vested and released
|
(71,579
|
)
|
|
$
|
50.88
|
|
|
Forfeited
|
(1,436
|
)
|
|
$
|
77.80
|
|
|
Outstanding — December 31, 2018
|
53,004
|
|
|
$
|
31.21
|
|
|
|
Number of
Shares
|
|
Weighted Average
Grant Date Fair Value
|
|||
|
Outstanding — January 1, 2017
|
—
|
|
|
$
|
—
|
|
|
Granted
|
6,917
|
|
|
$
|
26.54
|
|
|
Vested
|
(6,917
|
)
|
|
$
|
26.54
|
|
|
Outstanding — December 31, 2017
|
—
|
|
|
$
|
—
|
|
|
Granted
|
340,942
|
|
|
$
|
6.33
|
|
|
Vested
|
(340,942
|
)
|
|
$
|
6.33
|
|
|
Outstanding — December 31, 2018
|
—
|
|
|
$
|
—
|
|
|
|
Year Ended December 31,
|
||||||
|
|
2018
|
|
2017
|
||||
|
Cost of sales
|
$
|
47
|
|
|
$
|
370
|
|
|
Sales and marketing
|
310
|
|
|
2,095
|
|
||
|
Research and development
|
210
|
|
|
1,431
|
|
||
|
General and administrative
|
1,070
|
|
|
3,899
|
|
||
|
Total share-based compensation expense
|
$
|
1,637
|
|
|
$
|
7,795
|
|
|
13.
|
Net Loss per Share
|
|
|
December 31,
|
||||
|
|
2018
|
|
2017
|
||
|
Redeemable preferred shares
|
6,500,000
|
|
|
—
|
|
|
Common share purchase warrants
|
208,187
|
|
|
274,390
|
|
|
Restricted stock not yet vested or released
|
53,004
|
|
|
125,969
|
|
|
Options outstanding
|
20,050
|
|
|
23,536
|
|
|
Convertible notes
|
—
|
|
|
40,833
|
|
|
Convertible notes interest
|
—
|
|
|
40,945
|
|
|
14.
|
Income Taxes
|
|
|
Year Ended December 31,
|
||||||
|
|
2018
|
|
2017
|
||||
|
Domestic
|
$
|
(11,872
|
)
|
|
$
|
(5,295
|
)
|
|
Foreign
|
(743
|
)
|
|
(10,977
|
)
|
||
|
Total
|
$
|
(12,615
|
)
|
|
$
|
(16,272
|
)
|
|
|
Year Ended December 31,
|
||||||
|
|
2018
|
|
2017
|
||||
|
Deferred:
|
|
|
|
||||
|
Foreign
|
$
|
—
|
|
|
$
|
(852
|
)
|
|
Total deferred tax benefit
|
—
|
|
|
(852
|
)
|
||
|
Benefit from income taxes
|
$
|
—
|
|
|
$
|
(852
|
)
|
|
|
Year Ended December 31,
|
||||||
|
|
2018
|
|
2017
|
||||
|
Income tax at statutory rate
|
$
|
(3,343
|
)
|
|
$
|
(4,312
|
)
|
|
Foreign rate differential
|
—
|
|
|
(182
|
)
|
||
|
Change in tax rate
|
—
|
|
|
1,664
|
|
||
|
Change in valuation allowance
|
1,329
|
|
|
3,433
|
|
||
|
Share-based compensation expense
|
44
|
|
|
193
|
|
||
|
Prior year true-ups
|
111
|
|
|
—
|
|
||
|
Other differences
|
1,859
|
|
|
(1,648
|
)
|
||
|
Benefit from income taxes
|
$
|
—
|
|
|
$
|
(852
|
)
|
|
|
December 31,
|
||||||
|
|
2018
|
|
2017
|
||||
|
Deferred tax assets:
|
|
|
|
||||
|
Net operating loss carryforward
|
$
|
9,610
|
|
|
$
|
8,450
|
|
|
Intangible assets
|
2,280
|
|
|
2,270
|
|
||
|
Share-based compensation
|
52
|
|
|
94
|
|
||
|
Other
|
1,256
|
|
|
1,056
|
|
||
|
Deferred tax assets, gross
|
13,198
|
|
|
11,870
|
|
||
|
Valuation allowance for deferred tax assets
|
(13,198
|
)
|
|
(11,870
|
)
|
||
|
Deferred tax assets, net of valuation allowance
|
—
|
|
|
—
|
|
||
|
Deferred tax liabilities:
|
|
|
|
||||
|
Indefinite-lived intangible assets
|
(16
|
)
|
|
(16
|
)
|
||
|
Deferred tax liabilities
|
(16
|
)
|
|
(16
|
)
|
||
|
Net deferred tax liabilities
|
$
|
(16
|
)
|
|
$
|
(16
|
)
|
|
15.
|
Related Party Transactions
|
|
16.
|
401K Plan
|
|
17.
|
Commitments and Contingencies
|
|
|
|
Minimum
Lease Payments |
||
|
2019
|
|
$
|
168
|
|
|
2020
|
|
112
|
|
|
|
2021
|
|
66
|
|
|
|
Total
|
|
$
|
346
|
|
|
|
Product
Warranty |
|
Deferred
Revenue |
||||
|
Liability at January 1, 2017
|
$
|
—
|
|
|
$
|
749
|
|
|
Liabilities assumed from acquisition
|
—
|
|
|
518
|
|
||
|
Settlements made during the period
|
(23
|
)
|
|
(1,296
|
)
|
||
|
Change in liability for warranties issued during the period
|
24
|
|
|
1,566
|
|
||
|
Change in liability for pre-existing warranties
|
21
|
|
|
—
|
|
||
|
Liability at December 31, 2017
|
22
|
|
|
1,537
|
|
||
|
Settlements made during the period
|
—
|
|
|
(1,417
|
)
|
||
|
Change in liability for warranties issued during the period
|
—
|
|
|
1,351
|
|
||
|
Change in liability for pre-existing warranties
|
—
|
|
|
—
|
|
||
|
Liability at December 31, 2018
|
$
|
22
|
|
|
$
|
1,471
|
|
|
Current liability
|
$
|
22
|
|
|
$
|
825
|
|
|
Non-current liability
|
—
|
|
|
646
|
|
||
|
Liability at December 31, 2018
|
$
|
22
|
|
|
$
|
1,471
|
|
|
18.
|
Segmented Information
|
|
|
|
Year Ended December 31,
|
||||||
|
|
|
2018
|
|
2017
|
||||
|
Disk systems
|
|
$
|
6,108
|
|
|
$
|
9,698
|
|
|
Service
|
|
2,922
|
|
|
2,901
|
|
||
|
|
|
$
|
9,030
|
|
|
$
|
12,599
|
|
|
|
Year Ended December 31,
|
||||||
|
|
2018
|
|
2017
|
||||
|
Americas
|
$
|
8,044
|
|
|
$
|
11,121
|
|
|
APAC
|
534
|
|
|
823
|
|
||
|
EMEA
|
452
|
|
|
655
|
|
||
|
Total
|
$
|
9,030
|
|
|
$
|
12,599
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|